Sharck Soup Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Sharck Soup

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sharck who started this subject	5/24/2001 11:25:46 AM
From: besttrader	of 37746

Neurocrine Biosci (NBIX) 35.30 +0.16: UBS Warburg initiates coverage with a BUY rating and a 12-month price target of $46 based on substantial revenue and earnings growth expected from the company's primary products including NBI-34060 for the treatment of insomnia, and its 2 CRF products for the treatment of depression/anxiety. Business Objects (BOBJ) 36.40 -0.25: Dain Rauscher Wessels initiates coverage with a STRONG BUY AGGRESSIVE rating and price target of $45; firm cites the fact that BOBJ's products are used by more than 12,400 customers in more than 80 countries, including blue chip leaders such as AT&T, Chase Manhattan, and Eli Lilly. BellSouth (BLS) 41.00 -0.05: Prudential initiates coverage with a STRONG BUY rating and price target of $55; firm likes BLS based on valuation, and says that BLS has identified its strengths in customer relationships and access. 10:00 -- 11:00 ET (Updated throughout the hour)****** Sprint FON (FON) 20.22 +0.02: Prudential initiates coverage with a HOLD rating and price target of $22; firm sees minimal near term catalysts, and believes Sprint will have to gain visible traction with its growth initiatives.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next